Navigation Links
Nuvo Announces 2009 second quarter financial results
Date:8/7/2009

---------------------- NUVO RESEARCH INC. CONSOLIDATED STATEMENTS OF LOSS AND COMPREHENSIVE LOSS Three-months Six-months Unaudited ended ended (thousands of Canadian June 30, June 30, June 30, June 30, dollars except per share 2009 2008 2009 2008 and share amounts) $ $ $ $ ------------------------------------------------------------------------- REVENUE Product sales 2,075 1,795 4,458 3,770 Cost of goods sold 1,449 1,001 2,583 2,085 ------------------------------------------------------------------------- Gross margin on product sales 626 794 1,875 1,685 Other revenue Licensing fees 560 250 1,120 500 Research and other contract revenue 71 40 175 51 ------------------------------------------------------------------------- 1,257 1,084 3,170 2,236 ------------------------------------------------------------------------- EXPENSES Research and development 842 2,133 3,776 4,237 Selling, general and administrative expenses 1,791 1,162 3,154 2,286 Stock-based compensation 132 216 264 366 Amortization of property, plant, and equipment and intangibles 148 207 297 412 Foreign currency (gain) loss (210) 36 (219) (243) Interest expense 227 325 473 628 Interest income (9)
'/>"/>
SOURCE Nuvo Research Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. GeoVax Labs, Inc. Announces Six Month 2009 Financial Results and Provides Operational Update
2. NATB Announces Partnership With Ronald McDonald House Charities(R)
3. LCA Announces More Requests for Bids on Lung Cancer Research Programs Funded Through the Department of Defense
4. ThermoGenesis Announces Launch of Res-Q System; New Device Expands Companys Presence in Bone Marrow Sector
5. Orexigen(R) Therapeutics Announces Second Quarter 2009 Financial Results
6. AMN Healthcare Announces Second Quarter 2009 Results
7. IRIDEX Announces Second Quarter 2009 Conference Call and Release Date
8. NutraCea Announces Forbearance Agreement With Bank and Provides Update on Business Strategy and Transactions
9. ViroPharma Announces Initiation Of Non-Toxigenic Clostridium Difficile Phase 1 Program
10. Feline Pine Announces National Take Your Cat to the Vet Day August 22
11. MAP Pharmaceuticals, Inc. Announces Pricing of Public Offering of Common Stock

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...rch Triangle Dental (RTDental), a leading dental g...ounced the expansion of its services to include LU...Macmillan. , Durham, N...o announce that Dr. Doug Macmillan, an experienced...onal advanced training seminar. RTDental’s ...
(Date:11/25/2009)...RNewswire/--TheBartleHallConventionCenterwilltempo...-10,whenKansasCityhoststhelatestinaseriesofmassive...iceventhasthepotentialtobethebiggestoneyet,because...weekdaysinsteadofoveraweekend,"SheriWood,executive...toftheNationalAssociationofFreeClinics(NAFC). ,...
(Date:11/25/2009).../PRNewswire/--Thanksgivingmealswillbedeliveredtoap...achareathankstoFaithInAction/VolunteerActionforAgi...sionofSCANHealthPlan.Formorethan17yearstheseorgani...rmThanksgivingmealstoseniorsinneedinLongBeach,Lake...dingcities. ,, "Ourwarmholidaymealsaredelivered...
(Date:11/25/2009)...ents,Business,andPressJoinEfforttoEducate ,, M...ain,theNationalBipolarFoundationandtheMedicAlertFo...lStable"program,whichisnowbeingwidelyacceptedasapr...theNationalBipolarFoundationreceivedaproclamationo....GovernorofLouisianaMitchLandrieu.TheNationalBipol...
(Date:11/25/2009)...essure? This simple question has been the focus o...ated gene Modulates High Blood Pressure in Mice & ...imple question has been the focus of intense resea...first time established a link between a novel gene...ress in mice as well as humans. The studies were d...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Kansas City Prepares for Largest Free Health Clinic 2Health News:SCAN Employees and Community Volunteers to Help Deliver One Thousand Thanksgiving Meals to Homebound Seniors 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 2Health News:First Time-Door is Open for Family Discussion of Bipolar Disorder 3Health News:New stress-related gene modulates high blood pressure in mice and men 2
...ing to Researchers in CA, FL, IN, ME, NC, NY, SC, ... Physical Activity and Enhance Preventi...ON, N.J., May 27 More than $2 million,in grants w... players, health behaviors and outcomes. The grant...
...g European scientists say that there is an urgent ...tween Europes biobanks repositories of genetic an...hat can be used to investigate complex diseases su...well as increased and sustained funding for bioban...
...study by Newcastle University proves that organic ...d are producing better quality milk. , The Naffer...ing cows on organic farms in the UK produce milk w...ummer months, one of the beneficial fats in partic...
...on enables further growth and product development,...ta,analytics and business intelligence software to...today announced it was acquired by The Advisory,Bo...hance its existing platform and develop new produc...
...ter system enables hospital staff to overcome pote... transfusion safety., LENEXA, Kan., May 27 Mediw...www.mediware.com, a provider of,ClosedLoop(TM) cl...abel scanning and printing with Mediware,s HCLL bl...
... Calif., May 27 Isis,Pharmaceuticals, Inc. (Nasda....6 million dollars from Alnylam Pharmaceuticals, I... fees in the recently announced transaction,betwee...This transaction further emphasizes the value of I...
Other Medicine News:Health News:Video/Online Games for Health: 12 Research Teams From Across U.S. To Receive Major Grants 2Health News:Video/Online Games for Health: 12 Research Teams From Across U.S. To Receive Major Grants 3Health News:Europe's biobanks need urgent coordination -- scientists say 2Health News:UK's organic cows are cream of the crop 2Health News:UK's organic cows are cream of the crop 3Health News:Crimson Announces Acquisition by The Advisory Board Company 2Health News:All Children's Hospital Achieves ISBT 128 Compliance With Mediware's HCLL Blood Bank System 2Health News:All Children's Hospital Achieves ISBT 128 Compliance With Mediware's HCLL Blood Bank System 3Health News:Isis to Receive $4.6 Million From Alnylam 2Health News:Isis to Receive $4.6 Million From Alnylam 3
(Date:11/25/2009)...VELAND,Colo.,Nov.25/PRNewswire-FirstCall/--HeskaCo...nceddiagnosticandspecialtyproductstotheveterinaryi...csCorporationforthesupplyofbloodgasproductsandaffi...go: http://www.newscom.com/cgi-bin/prnh/20000622/H...forinnovatinginthefieldofadvancedpoint-of-carediag...
(Date:11/25/2009)...ICAGOandSTAFA,Switzerland,Nov.25/PRNewswire/-- Fro...vativehearingsolutions,presentedthesecondeditionof...cialneedsoftheolderpopulation.Theconferencebrought...dtheworldandmorethan250clinicianswhoworkeverydaywi...eexperiencesanddiscussthelatestresearchandtrendsin...
(Date:11/25/2009)...LLEGEPARK,Md.,Nov.25/PRNewswire-USNewswire/--Remed...m-likefoamthatstopsseverebleeding,wonfirstprizeand...GlobalSecurityChallenge2009,companyofficialsannoun...roundtheworld,Remedium,steampitchedtheirinventiona...olofBusiness. ,, Remedium( www.remediumtechnolo...
Breaking Medicine Technology:Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 2Phonak Successfully Hosts Hearing Care for Adults 2009 Conference 3Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 2Remedium Technologies Wins Most Promising Security Idea at Global Security Challenge 2009 with Blood-Clotting Foam 3Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 1Preventing H1N1 spread to health care workers 3A Dilemma debate and confusion 61746 2USC study to evaluate robots as exercise trainers 61744 1Weill Cornell science briefs 3A November 2009 10815 1Weill Cornell science briefs 3A November 2009 10815 2Weill Cornell science briefs 3A November 2009 10815 3Weill Cornell science briefs 3A November 2009 10815 4Weill Cornell science briefs 3A November 2009 10815 5
...Newswire/ -- Phase 3 results,from the RE-NOVATE(TM...e once daily, administered for an average of 33 da...red for an average of 33,days, in preventing venou...ter total hip replacement surgery. In this trial, ...ran etexilate was,similar to enoxaparin. The incid...
.../ -- A new study suggests,strong variation in the ... southern U.S. Anaphylaxis is a severe allergic,re...inephrine. The,striking north-south differences in... currently are without explanation. The,investigat...in D,from lack of sunshine, may play a role and th...
Other Medicine Technology:Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 2Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 3Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 4Phase 3 Results for Dabigatran Etexilate, an Investigational Oral,Anticoagulant, Presented Today at the XXIst Congress of the,International Society on Thrombosis and Haemostasis 5Large Geographic Differences in EpiPen Prescriptions in the U.S.,From the Journal of Allergy and Clinical Immunology 2
OCUFLOX® 5 mL
ALPHAGAN® 5 mL
ACULAR® 5 mL
ACULAR® 10 mL
Medicine Products: